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 Antioch University (“AU” or the “University”) is committed to the development and 
maintenance of an educational and workplace environment in compliance with the Drug- Free Schools 
and Communities Act of 1989 and the Drug-Free Workplace Act of 1988, and does not permit the 
unlawful possession, use, or distribution of illicit drugs and alcohol by students and employees on its 




The purpose of the Drug-Free Schools and Communities policy is to: 
1. Maintain learning and working environments free from alcohol and drug abuse; 
2. Educate students and employees about the consequences of alcohol and drug abuse; 
3. Inform students and employees that Antioch University will not tolerate alcohol and 
substance abuse in the learning and working environments, and to provide sanctions for 
violations of the policy; 
4. Inform students and employees of the resources available to them to help address 









alcohol and drug abuse; and 
5. Encourage students and employees with alcohol and/or drug abuse issues to get the 




A. Prohibitions. No student or employee may possess, use, transfer, distribute, 
manufacture or attempt to manufacture, or traffic in illicit drugs or alcohol in violation of state 
or federal law or attempt, solicit or conspire to commit any such offenses. This policy also 
prohibits these activities with synthetic or counterfeit substances that are an analogue for a 
controlled substance; the misuse, transfer, or sale of legal substances such as prescription 
drugs; and the possession or use of drug paraphernalia. 
 
B.  Federal Law Overrides Conflicting State or Local Laws. To remain eligible for federal 
funding of various programs and grants, including student financial aid, the University complies 
with all federal laws and regulations. Federal laws (including the Controlled Substances Act, 
the Drug Free Schools and Communities Act, and the Drug Free Workplace Act) make it illegal 
to possess, cultivate or sell marijuana. Thus, the University prohibits the cultivation, 
possession, use, or distribution of marijuana, even for state certified medical purposes, at 
University-sponsored events or activities and on University property. State or local laws that 
legalize certain drug-related conduct do not affect University drug policy. It is important to 
note that conviction for federal drug offences, including those related to marijuana, may result 
in a student’s loss of eligibility for federal financial aid. 
 
C. Application. The Drug-Free Schools and Communities Policy applies to all University 
campuses and extends to any worksite designated or used for the performance of work, any 
vehicles used for University work, and at any University-sponsored activities, including practica 
and internships. 
 
D.  Condition of Enrollment and Employment. As a condition of enrollment at the 
University, students are required to abide by this policy. Similarly, as a condition of 
employment, employees are required to abide by this policy. Violation of this policy may 
subject the violator to disciplinary action, including disenrollment or termination of 
employment.  
 
IV. Risks Associated with Alcohol and Drug Abuse 
 
 Risks from alcohol and drug abuse are numerous and wide-ranging. They include physical and 
mental impairment, emotional and psychological harm, and adverse effects on family and friends. The 
health risks from alcohol abuse include anemia, cancer, cardiovascular disease, cirrhosis, dementia, 
depression, gout, high blood pressure, infectious diseases, injuries to self and others, nerve damage, 
pancreatitis, seizures and stroke, and death. 
 
 Drug abuse causes similar health risks. The universe of illicit drugs is large and varied, as are 
 
 
the attendant risks. The National Institute on Drug Abuse compiles Common Drugs of Abuse charts, 
which list the risks associated with particular drugs. Those charts, dated March 2015, are incorporated 
and appended as Appendix A. For what may be more current information from the National Institute 
on Drug Abuse, see the Common Drugs of Abuse charts at the National Institute on Drug Abuse 
website: http://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs-charts-0. 
 
 An abuser of drugs and/or alcohol causes risks to self as well as to other students or co-workers 
and the community, including accidents, decreased productivity, increased stress, and injuries. 
Alcohol and other drug abuse can contribute to poor academic and/or job performance, poor social 
interactions, unwanted sexual activity and sexually transmitted diseases, and can jeopardize career 
prospects (e.g., admission to law school, government employment). 
 
V. Sanctions under Federal, State, and Local Law 
 
A. Cooperation with Law Enforcement. The University cooperates fully with law 
enforcement authorities. The University may refer violations of this policy (and other 
University policies including the Student Conduct Policy and Employee Conduct Policy) that are 
also violations of federal, state or local law to the appropriate authorities. In such situations, 
cases may proceed concurrently in the University system and in the criminal justice system. 
 
B.  Sanctions. There are federal, state, and local sanctions for violations of drug and alcohol laws. 
A listing of federal sanctions from the Drug Enforcement Agency (DEA) as of July 2015 is incorporated 
by reference and appended as Appendix B and C. Listings of sanctions as of July 2015 from the states 
of Ohio, New Hampshire, Washington, and California, including ordinances from the City of Los 
Angeles are incorporated by reference and appended as Appendix D, E, F, and G respectively. As 
sanctions for violations of drug and alcohol laws change regularly, it is the responsibility of students 
and employees to ascertain if there are new or updated sanctions that may be relevant.  
 In addition, students should be aware that a conviction on a federal drug charge will 
result in denial of federal benefits (including eligibility for federal financial aid) under 21 U.S.C. 
§ 862. 
 
C.  Marijuana Policy. It is important to note that some state or local laws may allow 
marijuana use, possession, processing or distribution that is also prohibited under federal law. 
Therefore, such drug-related conduct that is allowed under state law may also be prosecuted 
under federal law. As a recipient of federal Title IV financial aid funds, Antioch University 
prohibits all drug-related conduct that violates federal law on University campuses and in 
University programs and activities, regardless of state or local laws. 
 
VI. Consequences of Policy Violation for Students 
 
 One of the goals of this policy is to encourage students to voluntarily seek help with alcohol 
and/or drug problems. However, if an individual violates the policy, the consequences are serious. 
 
 Any student who violates this policy, and therefore also Student Conduct Policy, 6.103, is 
subject to the process and sanctions outlined in the Student Conduct Policy. Those sanctions may 
 
 
include, but are not limited to formal reprimand, required counseling or treatment, mandatory leave, 
and disenrollment from the University. 
 
 In determining the appropriate sanction for violation of this policy, the University may, at a 
minimum, consider the following circumstances: 
 
1. How the violation was committed; 
 
2. The amount and nature of the alcohol and/or drug(s) involved; 
 
3. The level of knowledge and intent of the student(s); 
 
4. Disruption to the learning and working environments; and 
 
5. Prior conduct of the student(s). 
 
This list is not exhaustive and other circumstances may be considered when determining sanctions. 
 
VII. Employee Notice to University of Conviction 
 
 As a condition of employment and as required by federal law, any employee who is convicted 
of unlawfully possessing, using, dispensing, distributing, or manufacturing any controlled substances 
or illicit drugs within the workplace, must notify the local Human Resources Director in writing within 
five (5) calendar days of the conviction. 
 
 If the employee is directly engaged in performance of work pursuant to the provisions of a 
federal grant or federal contract, the University shall give notice of the conviction to the federal agency 
with whom it has contracted or from whom it received the grant within ten (10) calendar days of 
receiving notification of conviction. 
 
VIII. Consequences of Policy Violation for Employees 
 
 One of the goals of this policy is to encourage employees to voluntarily seek help with alcohol 
and/or drug problems. However, if an individual violates the policy, the consequences are serious. 
 
 Upon determination of a violation of this policy or within thirty days after receiving notice of a 
conviction, the University shall take appropriate disciplinary or referral action. Discipline for violating 
this policy shall be governed by the University’s Corrective Action and Discipline Policy 4.617. Nothing 
in this policy limits the right of the University under federal, state or local law to discipline the 
employee, up to and including termination, for violation of any University policy or rule. In addition to 
University discipline, civil or criminal penalties may apply including fines and/or incarceration 
depending on federal, state or local law. 
 
 In lieu of or as part of any disciplinary sanctions for violation of this policy, the University in its 
discretion may require the employee to satisfactorily participate in or complete alcohol or drug abuse 
 
 
assistance or rehabilitation programs designated by the University and approved for such purposes by 
a federal, state or local health, law enforcement, or other appropriate agency. 
 
IX. Drug and Alcohol Abuse Prevention Program 
 
 In support of the goals of this policy, the University shall maintain a drug and alcohol 
abuse prevention program for all students and employees. 
A. Contents of Drug and Alcohol Abuse Prevention Program 
 The University shall maintain a drug and alcohol abuse prevention program to inform 
all students and employees about this policy and: 
1. The University’s intent to maintain drug-free learning and working 
environments; 
 
2. The risks of drug abuse in the learning and working environments; 
 
3. Drug or alcohol counseling, treatment, and rehabilitation/re-entry programs 
that are available to students and employees; 
 
4. The employee assistance program; and 
 
5. Penalties that may be imposed for violation of this policy and a 
description of the applicable legal sanctions under federal, state and local law for 
the unlawful possession or distribution of illicit drugs and alcohol. 
B. Confidentiality 
 All information received by the University through the drug and alcohol abuse 
prevention program is confidential. Access to this information is limited to those who have a 
legitimate need to know in compliance with relevant laws and policies. 
C. Biennial Review of Drug and Alcohol Abuse Prevention Program 
 
 Pursuant to the Drug-Free Schools and Communities Act, the University shall conduct 
a biennial review to determine the effectiveness of its drug and alcohol abuse prevention 
program, and to ensure consistent enforcement of application drug and alcohol-related 
statutes, ordinances, and University policies against students and employees found to be in 
violation. 
 
 The University will maintain the biennial review materials to provide to the federal 
Department of Education upon request. 
 
D. Disclosure of Drug Abuse and Alcohol Prevention Program 
 The University will disclose the provisions of its Drug Abuse and Alcohol Prevention 
Program to all students and employees annually, along with its disclosure to students and 
 
 
employees of the Annual Security Report under the Clery Act on or before October 1 each year. 
For those individual students who enroll after October 1 and those individual employees who 
are hired after October 1, the University will disclose its most recent Drug Abuse and Alcohol 
Prevention Program materials as part of the students’ orientation materials and through the 
Office of Human Resources upon hire, respectively. 
 
X. Student and Employee Assistance Programs 
 
 Students and employees who are struggling with alcohol or drugs are strongly encouraged to 
seek assistance. Students may seek advice from their advisor, or the campus Student Services officer. 
 
 Each campus and program has information regarding inpatient and outpatient facilities, 
recovery meetings, and counseling services in the vicinity of that campus. For students and employees 
who live at a distance from campus, the University will provide relevant information to each person 
who requests it. 
 
 The University’s Employee Assistance Program (EAP) is available free of charge to employees 
and their families on a confidential basis. Employees who have a concern about drug or alcohol abuse 
are strongly encouraged to contact the Office of Human Resources for assistance in finding the right 




A. Common Drugs of Abuse charts from the National Institute on Drug Abuse 
 
B. DEA Federal Penalty Chart 1 
 
C. DEA Federal Penalty Chart 2 
 
D. Ohio Drug and Alcohol Law Summary 
 
E. New Hampshire Drug and Alcohol Law Summary 
 
F. Washington State Drug and Alcohol Law Summary 
 
G. California and Los Angeles Drug and Alcohol Law Summary 
 
 
Policy Cross Reference 
 
This policy updates Policy 4.505, formerly entitled “Drug Free Workplace.” 
 
Corrective Action and Discipline Procedure Policy # 4.617 
Student Conduct Policy # 6.103 









Common Drugs of Abuse 
 
Most drugs of abuse are addictive. Addiction is a chronic, relapsing disease characterized by compulsive drug seeking 
and use despite negative consequences and by long-lasting changes in the brain. People who are addicted have strong 
cravings for the drug, making it difficult to stop using. Most drugs alter a person’s thinking and judgment, which can 
increase the risk of injury or death from drugged driving or infectious diseases (e.g., HIV/AIDS, hepatitis) from unsafe 
sexual practices or needle sharing. Drug use during pregnancy can lead to neonatal abstinence syndrome, a condition in 
which a baby can suffer from dependence and withdrawal symptoms after birth. Pregnancy-related issues are listed in 
the chart below for drugs where there is enough scientific evidence to connect the drug use to negative effects. 
However, most drugs could potentially harm an unborn baby. 
 
In the chart, the Drug Enforcement Agency (DEA) schedule indicates the drug’s acceptable medical use and its potential 
for abuse or dependence. More information can be found on the DEA website. For more comprehensive information 
about treatment options for drug addiction, see NIDA’s Principles of Drug Addiction Treatment: A Research-Based Guide 
(Third Edition). 
 













 Marijuana (Cannabis) 
 MDMA (Ecstasy/Molly) 
 
 
 Mescaline (Peyote) 
 Methamphetamine 
 Over-the-counter Cough/Cold Medicines (Dextromethorphan or DMX) 
 PCP 
 Prescription Opioids 
 Prescription Sedatives 
 Prescription Stimulants 
 Psilocybin 
 Salvia 
 Steroids (Anabolic) 
 Synthetic Cannabinoids (“K2” / “Spice”) 
 Tobacco 
National Institute on Drug Abuse 
Common Drugs of Abuse  




People drink to socialize, celebrate, and relax. Alcohol often has a strong effect on people – and throughout 
history, people have struggled to understand and manage alcohol’s power. Why does alcohol cause people to act and 
feel differently? How much is too much? Why do some people become addicted while others do not? The National 
Institute on Alcohol Abuse and Alcoholism is researching the answers to these, and many other questions about 
alcohol. Here’s what is known: 
Alcohol’s effects vary from person to person, depending on a variety of factors, including: 
 How much you drink 
 How often you drink 
 Your age 
 Your health status 
 Your family history 
 
While drinking alcohol is itself not necessarily a problem – drinking too much can cause a range of consequences, and 
increase your risk for a variety of problems. For more information on alcohol’s effects on the body, please see 
the National Institute on Alcohol Abuse and Alcoholism’s related web page describing alcohol’s effects on the body. 
National Institute on Drug Abuse 
Common Drugs of Abuse  
Page 3 of 26 
 
Ayahuasca 
A hallucinogenic tea made in the Amazon from a DMT-containing plant (Psychotria viridis or Diplopterys cabrerana or 
other) along with another vine (Banisteriopsis caapi) that contains an MAO Inhibitor preventing the natural 
breakdown of DMT in the digestive system, thereby facilitating a prolonged hallucinatory experience. It was used 
historically in Amazonian religious and healing rituals and is increasingly used by tourists. For more information, see 
the Hallucinogens and Dissociative Drugs Research Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 




g it are 
not 
controlled 
Possible Health Effects 
Short-term Strong hallucinations including perceptions of otherworldly imagery, altered visual and 












Medications It is not known whether ayahuasca is addictive. There are no FDA-approved medications to 
treat addiction to ayahuasca or other hallucinogens. 
Behavioral Therapies More research is needed to find out if ayahuasca is addictive and, if so, whether behavioral 
therapies are effective. 
National Institute on Drug Abuse 
Common Drugs of Abuse  
Page 4 of 26 
 
Bath Salts (Synthetic Cathinones) 
An emerging family of drugs containing one or more synthetic chemicals related to cathinone, a stimulant found 
naturally in the Khat plant. Examples of such chemicals include mephedrone, methylone, and 3,4- 
methylenedioxypyrovalerone (MDPV). For more information, see the Bath Salts DrugFacts. 




Bloom, Cloud Nine, 
Cosmic Blast, Ivory 
Wave, Lunar Wave, 
Scarface, Vanilla Sky, 
White Lightning 
No commercial uses 
for ingested “bath 
salts” 
White or brown crystalline 
powder sold in small plastic 
or foil packages labeled “not 
for human consumption” and 
sometimes sold as jewelry 











Possible Health Effects 
Short-term Increased heart rate and blood pressure; euphoria; increased sociability and sex drive; 
paranoia, agitation, and hallucinations; psychotic and violent behavior; nosebleeds; 
sweating; nausea, vomiting; insomnia; irritability; dizziness; depression; suicidal thoughts; 
panic attacks; reduced motor control; cloudy thinking. 
Long-term Breakdown of skeletal muscle tissue; kidney failure; death. 
Other Health-related 
Issues 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 





Depression, anxiety, problems sleeping, tremors, paranoia. 
Treatment Options 
Medications There are no FDA-approved medications to treat addiction to bath salts. 
Behavioral Therapies  Cognitive-behavioral therapy (CBT) 
 Contingency management, or motivational incentives 
 Motivational Enhancement Therapy (MET) 
 Behavioral treatments geared to teens 
National Institute on Drug Abuse 
Common Drugs of Abuse  
Page 5 of 26 
 
Cocaine 
A powerfully addictive stimulant drug made from the leaves of the coca plant native to South America. For more 
information, see the Cocaine Research Report. 




Blow, Bump, C, Candy, 
Charlie, Coke, Crack, 




(anesthetic rarely used 
in medical procedures) 





Possible Health Effects 
Short-term Narrowed blood vessels; enlarged pupils; increased body temperature, heart rate, and blood 
pressure; headache; abdominal pain and nausea; euphoria; increased energy, alertness; 
insomnia, restlessness; anxiety; erratic and violent behavior, panic attacks, paranoia, 
psychosis; heart rhythm problems, heart attack; stroke, seizure, coma. 
Long-term Loss of sense of smell, nosebleeds, nasal damage and trouble swallowing from snorting; 
infection and death of bowel tissue from decreased blood flow; poor nutrition and weight 
loss from decreased appetite. 
Other Health-related 
Issues 
Pregnancy: premature delivery, low birth weight, neonatal abstinence syndrome. 
 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 
In Combination with 
Alcohol 
Greater risk of overdose and sudden death than from either drug alone. 
Withdrawal 
Symptoms 
Depression, tiredness, increased appetite, insomnia, vivid unpleasant dreams, slowed 
thinking and movement, restlessness. 
Treatment Options 
Medications There are no FDA-approved medications to treat cocaine addiction. 
Behavioral Therapies  Cognitive-behavioral therapy (CBT) 
 Community reinforcement approach plus vouchers 
 Contingency management, or motivational incentives 
 The matrix model 
 12-Step facilitation therapy 
National Institute on Drug Abuse 
Common Drugs of Abuse  
Page 6 of 26 
 
DMT 
A synthetic drug producing intense but relatively short-lived hallucinogenic experiences; also naturally occurring in 
some South American plants (See Ayahuasca). For more information, see the Hallucinogens and Dissociative Drugs 
Research Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 
DMT, Dimitri No commercial uses White or yellow 
crystalline powder 
Smoked, injected I 
Possible Health Effects 
Short-term Intense visual hallucinations, depersonalization, auditory distortions, and an altered 
perception of time and body image, usually resolving in 30-45 minutes or less. Physical 
effects include hypertension, increased heart rate, agitation, seizures, dilated pupils, 




At high doses, coma and respiratory arrest have occurred. 







Medications It is not known whether DMT is addictive. There are no FDA-approved medications to treat 
addiction to DMT or other hallucinogens. 
Behavioral Therapies More research is needed to find out if DMT is addictive and, if so, whether behavioral 
therapies are effective. 
National Institute on Drug Abuse 
Common Drugs of Abuse  
Page 7 of 26 
 
GHB 
A depressant approved for use in the treatment of narcolepsy, a disorder that causes daytime “sleep attacks.” For 
more information, see the Club Drugs DrugFacts. 




G, Georgia Home Boy, 
Goop, Grievous Bodily 
Harm, Liquid Ecstasy, 









alcohol or other 
beverages) 
I 
Possible Health Effects 
Short-term Euphoria, drowsiness, decreased anxiety, confusion, memory loss, hallucinations, excited 
and aggressive behavior, nausea, vomiting, unconsciousness, seizures, slowed heart rate and 




Sometimes used as a date rape drug. 
In Combination with 
Alcohol 
Nausea, problems with breathing, greatly increased depressant effects. 
Withdrawal 
Symptoms 









Drugs that cause profound distortions in a person’s perceptions of reality, such as ketamine, LSD, mescaline (peyote), 
PCP, psilocybin, salvia, DMT, and ayahuasca. For more information, see the Hallucinogens and Dissociative Drugs 
Research Report. 
National Institute on Drug Abuse 
Common Drugs of Abuse  
Page 8 of 26 
 
Heroin 
An opioid drug made from morphine, a natural substance extracted from the seed pod of the Asian opium poppy 
plant. For more information, see the Heroin Research Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 
Brown sugar, China 
White, Dope, H, Horse, 
Junk, Skag, Skunk, 
Smack, White Horse 
With OTC cold 
medicine and 
antihistamine: Cheese 
No commercial uses White or brownish 
powder, or black sticky 
substance known as 




Possible Health Effects 
Short-term Euphoria; warm flushing of skin; dry mouth; heavy feeling in the hands and feet; clouded 
thinking; alternate wakeful and drowsy states; itching; nausea; vomiting; slowed breathing 
and heart rate. 
Long-term Collapsed veins; abscesses (swollen tissue with pus); infection of the lining and valves in the 
heart; constipation and stomach cramps; liver or kidney disease; pneumonia. 
Other Health-related 
Issues 
Pregnancy: miscarriage, low birth weight, neonatal abstinence syndrome. 
 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 
In Combination with 
Alcohol 
Dangerous slowdown of heart rate and breathing, coma, death. 
Withdrawal 
Symptoms 
Restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, cold flashes with goose 
bumps ("cold turkey"), leg movements. 
Treatment Options 
Medications  Methadone 
 Buprenorphine 
 Naltrexone (short and long-acting forms) 
Behavioral Therapies  Contingency management, or motivational incentives 
 12-Step facilitation therapy 
National Institute on Drug Abuse 
Common Drugs of Abuse  
Page 9 of 26 
 
Inhalants 
Solvents, aerosols, and gases found in household products such as spray paints, markers, glues, and cleaning fluids; 
also nitrites (e.g., amyl nitrite), which are prescription medications for chest pain. For more information, see the 
Inhalants Research Report. 





whippets, laughing gas 
Various Paint thinners or removers, 
degreasers, dry-cleaning 
fluids, gasoline, lighter fluids, 
correction fluids, permanent 
markers, electronics cleaners 
and freeze sprays, glue, spray 
paint, hair or deodorant 
sprays, fabric protector 
sprays, aerosol computer 
cleaning products, vegetable 
oil sprays, butane lighters, 
propane tanks, whipped 
cream aerosol containers, 
refrigerant gases, ether, 
chloroform, halothane, 
nitrous oxide 
Inhaled through the 
nose or mouth 
Not 
scheduled 
Possible Health Effects 
Short-term Confusion; nausea; slurred speech; lack of coordination; euphoria; dizziness; drowsiness; 
disinhibition, lightheadedness, hallucinations/delusions; headaches; sudden sniffing death 
due to heart failure (from butane, propane, and other chemicals in aerosols); death from 
asphyxiation, suffocation, convulsions or seizures, coma, or choking. 
 
Nitrites: enlarged blood vessels, enhanced sexual pleasure, increased heart rate, brief 
sensation of heat and excitement, dizziness, headache. 
Long-term Liver and kidney damage; bone marrow damage; limb spasms due to nerve damage; brain 
damage from lack of oxygen that can cause problems with thinking, movement, vision, and 
hearing. 
 
Nitrites: increased risk of pneumonia. 
Other Health-related 
Issues 
Pregnancy: low birth weight, bone problems, delayed behavioral development due to brain 
problems, altered metabolism and body composition. 
In Combination with 
Alcohol 
Nitrites: dangerously low blood pressure. 
Withdrawal 
Symptoms 
Nausea, loss of appetite, sweating, tics, problems sleeping, and mood changes. 
Treatment Options 
Medications There are no FDA-approved medications to treat inhalant addiction. 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat inhalant 
addiction. 
National Institute on Drug Abuse 
Common Drugs of Abuse 
March 2015 
Page 10 of 26 
 
Ketamine 
A dissociative drug used as an anesthetic in veterinary practice. Dissociative drugs are hallucinogens that cause the 
user to feel detached from reality. For more information, see the Hallucinogens and Dissociative Drugs Research 
Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 
Cat Valium, K, Special 
K, Vitamin K 
Ketalar® Liquid, white powder Injected , snorted, 
smoked (powder 




Possible Health Effects 
Short-term Problems with attention, learning, and memory; dreamlike states, hallucinations; sedation; 
confusion and problems speaking; loss of memory; problems moving, to the point of being 
immobile; raised blood pressure; unconsciousness; slowed breathing that can lead to death. 
Long-term Ulcers and pain in the bladder; kidney problems; stomach pain; depression; poor memory. 
Other Health-related 
Issues 
Sometimes used as a date rape drug. 
 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 
In Combination with 
Alcohol 





Medications There are no FDA-approved medications to treat addiction to ketamine or other dissociative 
drugs. 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat addiction to 
dissociative drugs. 
National Institute on Drug Abuse 
Common Drugs of Abuse 
March 2015 
Page 11 of 26 
 
LSD 
A hallucinogen manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains. 
LSD is an abbreviation of the scientific name, lysergic acid diethylamide. For more information, see the Hallucinogens 
and Dissociative Drugs Research Report. 








No commercial uses Tablet; capsule; clear liquid; 
small, decorated squares of 
absorbent paper that liquid 






Possible Health Effects 
Short-term Rapid emotional swings; distortion of a person’s ability to recognize reality, think rationally, 
or communicate with others; raised blood pressure, heart rate, body temperature; dizziness 
and insomnia; loss of appetite; dry mouth; sweating; numbness; weakness; tremors; 
enlarged pupils. 
Long-term Frightening flashbacks (called Hallucinogen Persisting Perception Disorder ([HPPD]); ongoing 




In Combination with 
Alcohol 





Medications There are no FDA-approved medications to treat addiction to LSD or other hallucinogens. 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat addiction to 
hallucinogens. 
National Institute on Drug Abuse 
Common Drugs of Abuse 
March 2015 
Page 12 of 26 
 
Marijuana (Cannabis) 
Marijuana is made from the hemp plant, Cannabis sativa. The main psychoactive (mind-altering) chemical in 
marijuana is delta-9-tetrahydrocannabinol, or THC. For more information, see the Marijuana Research Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 
Blunt, Bud, Dope, 
Ganja, Grass, Green, 
Herb, Joint, Mary 
Jane, Pot, Reefer, 
Sinsemilla, Skunk, 
Smoke, Trees, Weed; 
Hashish: Boom, 
Gangster, Hash, Hemp 
Various brand names in 
states where the sale 
of marijuana is legal 
Greenish-gray mixture of 
dried, shredded leaves, 
stems, seeds, and/or 
flowers; resin (hashish) or 
sticky, black liquid (hash 
oil) 
Smoked, eaten (mixed in 
food or brewed as tea) 
I 
Possible Health Effects 
Short-term Enhanced sensory perception and euphoria followed by drowsiness/relaxation; slowed 
reaction time; problems with balance and coordination; increased heart rate and appetite; 
problems with learning and memory; hallucinations; anxiety; panic attacks; psychosis. 
Long-term Mental health problems; chronic cough; frequent respiratory infections. 
Other Health-related 
Issues 
Youth: possible loss of IQ points when repeated use begins in adolescence. 
 
Pregnancy: babies born with problems with attention, memory, and problem solving. 
In Combination with 
Alcohol 




Irritability, trouble sleeping, decreased appetite, anxiety. 
Treatment Options 
Medications There are no FDA-approved medications to treat marijuana addiction. 
Behavioral Therapies  Cognitive-behavioral therapy (CBT) 
 Contingency management, or motivational incentives 
 Motivational Enhancement Therapy (MET) 
 Behavioral treatments geared to adolescents 
National Institute on Drug Abuse 
Common Drugs of Abuse 
March 2015 
Page 13 of 26 
 
MDMA (Ecstasy/Molly)  
A synthetic, psychoactive drug that has similarities to both the stimulant amphetamine and the hallucinogen 
mescaline. MDMA is an abbreviation of the scientific name, 3,4-methylenedioxy-methamphetamine. For more 
information, see the MDMA (Ecstasy) Abuse Research Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 
Adam, Clarity, Eve, 
Lover's Speed, Peace, 
Uppers 
No commercial uses Colorful tablets with 
imprinted logos, 
capsules, powder, liquid 
Swallowed, snorted I 
Possible Health Effects 
Short-term Lowered inhibition; enhanced sensory perception; confusion; depression; sleep problems; 
anxiety; increased heart rate and blood pressure; muscle tension; teeth clenching; nausea; 
blurred vision; faintness; chills or sweating; sharp rise in body temperature leading to liver, 
kidney, or heart failure and death. 
Long-term Long-lasting confusion, depression, problems with attention, memory, and sleep; increased 




In Combination with 
Alcohol 
May increase the risk of cell and organ damage. 
Withdrawal 
Symptoms 
Fatigue, loss of appetite, depression, trouble concentrating. 
Treatment Options 
Medications There is conflicting evidence about whether MDMA is addictive. There are no FDA-approved 
medications to treat MDMA addiction. 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat MDMA 
addiction. 
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Mescaline (Peyote) 
A hallucinogen found in disk-shaped “buttons” in the crown of several cacti, including peyote. For more information, 
see the Hallucinogens – LSD, Peyote, Psilocybin, and PCP DrugFacts. 




Buttons, Cactus, Mesc No commercial uses Fresh or dried buttons, 
capsule 
Swallowed (chewed 
or soaked in water 
and drunk) 
I 
Possible Health Effects 
Short-term Enhanced perception and feeling; hallucinations; euphoria; anxiety; increased body 












Medications There are no FDA-approved medications to treat addiction to mescaline or other 
hallucinogens. 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat addiction to 
hallucinogens. 
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Methamphetamine 
An extremely addictive stimulant amphetamine drug. For more information, see the Methamphetamine Research 
Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 
Crank, Chalk, Crystal, 
Fire, Glass, Go Fast, 
Ice, Meth, Speed 
Desoxyn® White powder or pill; 
crystal meth looks like 
pieces of glass or shiny 





Possible Health Effects 
Short-term Increased wakefulness and physical activity; decreased appetite; increased breathing, heart 
rate, blood pressure, temperature; irregular heart beat. 
Long-term Anxiety, confusion, insomnia, mood problems, violent behavior; paranoia, hallucinations, 
delusions, weight loss, severe dental problems (“meth mouth”), intense itching leading to 
skin sores from scratching. 
Other Health-related 
Issues 
Pregnancy: premature delivery; separation of the placenta from the uterus; low birth 
weight; lethargy; heart and brain problems. 
 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 
In Combination with 
Alcohol 
Masks the depressant effect of alcohol, increasing risk of alcohol overdose; may increase 
blood pressure and jitters. 
Withdrawal 
Symptoms 
Depression, anxiety, tiredness. 
Treatment Options 
Medications There are no FDA-approved medications to treat methamphetamine addiction. 
Behavioral Therapies  Cognitive-behavioral therapy (CBT) 
 Contingency management or motivational incentives 
 The matrix model 
 12-Step facilitation therapy 
National Institute on Drug Abuse 
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Over-the-counter Cough/Cold Medicines (Dextromethorphan or DMX) 
Psychoactive when taken in higher-than-recommended amounts. For more information, see the Cough and Cold 
Medicine Abuse DrugFacts. 




Various (many brand 
names include “DM”) 
Syrup, capsule Swallowed Not 
scheduled 
Possible Health Effects 
Short-term Euphoria; slurred speech; increased heart rate, blood pressure, temperature; numbness; 
dizziness; nausea; vomiting; confusion; paranoia; altered visual perceptions; problems with 




Breathing problems, seizures, and increased heart rate may occur from other ingredients in 
cough/cold medicines. 
In Combination with 
Alcohol 





Medications There are no FDA-approved medications to treat addiction to over-the-counter cough/cold 
medicines. 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat addiction to 
over-the-counter cough/cold medicines. 
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PCP 
A dissociative drug developed as an intravenous anesthetic that has been discontinued due to serious adverse effects. 
Dissociative drugs are hallucinogens that cause the user to feel detached from reality. PCP is an abbreviation of the 
scientific name, phencyclidine. For more information, see the Hallucinogens and Dissociative Drugs Research Report. 




Angel Dust, Boat, Hog, 
Love Boat, Peace Pill 
No commercial uses White or colored powder, 
tablet, or capsule; clear liquid 
Injected, snorted, 
swallowed, smoked 





Possible Health Effects 
Short-term Delusions, hallucinations, paranoia, problems thinking, a sense of distance from one’s 
environment, anxiety. 
 
Low doses: slight increase in breathing rate; increased blood pressure and heart rate; 
shallow breathing; face redness and sweating; numbness of the hands or feet; problems 
with movement. 
 
High doses: lowered blood pressure, pulse rate, breathing rate; nausea; vomiting, blurred 
vision; flicking up and down of the eyes; drooling; loss of balance; dizziness; violence; 
suicidal thoughts; seizures, coma, and death. 
Long-term Memory loss, problems with speech and thinking, depression, weight loss, anxiety. 
Other Health-related 
Issues 
PCP has been linked to self-injury. 
 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 
In Combination with 
Alcohol 





Medications There are no FDA-approved medications to treat addiction to PCP or other dissociative 
drugs. 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat addiction to 
dissociative drugs. 
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 Prescription Opioids 
Pain relievers with an origin similar to that of heroin. Opioids can cause euphoria and are often used nonmedically, 
leading to overdose deaths. For more information, see the Prescription Drug Abuse Research Report. 
Street Names Commercial Names 
(Common) 
Common Forms Common Ways Taken DEA 
Schedule 
Captain Cody, Cody, 
Lean, Schoolboy, 
Sizzurp, Purple Drank 
Codeine (various brand 
names) 
Tablet, capsule, liquid Injected, swallowed 
(often mixed with soda 
and flavorings) 
II, III, V 
With glutethimide: 
Doors & Fours, Loads, 
Pancakes and Syrup 
    
Apache, China Girl, 
China White, Dance 
Fever, Friend, 
Goodfella, Jackpot, 










Vike, Watson-387 Hydrocodone or 
dihydrocodeinone 
(Vicodin®, Lortab®, 
Lorcet®, and others) 
Capsule, liquid, tablet Swallowed, snorted, 
injected 
II 




Liquid, suppository Injected, rectal II 










Tablet, dispersible tablet, 
liquid 
Swallowed, injected II 
M, Miss Emma, 









O.C., Oxycet, Oxycodone Capsule, liquid, tablet Swallowed, snorted, II 
Oxycotton, Oxy, (OxyContin®,  injected  
Hillbilly Heroin, Percs Percodan®, Percocet®,    
 and others)    
Biscuits, Blue Heaven, Oxymorphone Tablet Swallowed, snorted, II 
Blues, Mrs. O, O (Opana®)  injected  
Bomb, Octagons, Stop     
Signs     
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Possible Health Effects 




Pregnancy: Miscarriage; low birth weight; neonatal abstinence syndrome. 
 
Older Adults: Higher risk of accidental misuse or abuse because many older adults have 
multiple prescriptions, increasing the risk of drug-drug interactions, and breakdown of drugs 
slows with age; also, many older adults are treated with prescription medications for pain. 
 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 
In Combination with 
Alcohol 
Dangerous slowing of heart rate and breathing leading to coma or death. 
Withdrawal 
Symptoms 
Restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, cold flashes with goose 
bumps ("cold turkey"), leg movements. 
Treatment Options 
Medications  Methadone 
 Buprenorphine 
 Naltrexone (short- and long-acting) 
Behavioral Therapies Behavioral therapies that have helped treat addiction to heroin may be useful in treating 
prescription opioid addiction. 
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Prescription Sedatives (tranquilizers, depressants) 
Medications that slow brain activity, which makes them useful for treating anxiety and sleep problems. For more 
information, see the Prescription Drug Abuse Research Report. 
Street Names Commercial Names 
(Common) 
Common Forms Common Ways Taken DEA 
Schedule 
Barbs, Phennies, Red 








Pill, capsule, liquid Swallowed, injected II, III, IV 
Candy, Downers, 








Pill, capsule, liquid Swallowed, snorted IV 
Forget-me Pill, 








Pill, capsule, liquid Swallowed, snorted IV 
Possible Health Effects 
Short-term Drowsiness, slurred speech, poor concentration, confusion, dizziness, problems with 




Sleep medications are sometimes used as date rape drugs. 
 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 
In Combination with 
Alcohol 
Further slows heart rate and breathing, which can lead to death. 
Withdrawal 
Symptoms 
Must be discussed with a health care provider; barbiturate withdrawal can cause a serious 
abstinence syndrome that may even include seizures. 
Treatment Options 
Medications There are no FDA-approved medications to treat addiction to prescription sedatives; 
lowering the dose over time must be done with the help of a health care provider. 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat addiction to 
prescription sedatives. 
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Prescription Stimulants 
Medications that increase alertness, attention, energy, blood pressure, heart rate, and breathing rate. For more 
information, see the Prescription Drug Abuse Research Report. 
Street Names Commercial Names 
(Common) 










Tablet, capsule Swallowed, snorted, 
smoked, injected 
II 
JIF, MPH, R-ball, 
Skippy, The Smart 
Drug, Vitamin R 
Methylphenidate 
(Concerta®, Ritalin®) 






Possible Health Effects 
Short-term Increased alertness, attention, energy; increased blood pressure and heart rate; narrowed 
blood vessels; increased blood sugar; opened up breathing passages. 
 
High doses: dangerously high body temperature and irregular heartbeat; heart failure; 
seizures. 
Long-term Heart problems, psychosis, anger, paranoia. 
Other Health-related 
Issues 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 
In Combination with 
Alcohol 
Masks the depressant action of alcohol, increasing risk of alcohol overdose; may increase 
blood pressure and jitters. 
Withdrawal 
Symptoms 
Depression, tiredness, sleep problems. 
Treatment Options 
Medications There are no FDA-approved medications to treat stimulant addiction. 
Behavioral Therapies Behavioral therapies that have helped treat addiction to cocaine or methamphetamine may 
be useful in treating prescription stimulant addiction. 
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Psilocybin 
A hallucinogen in certain types of mushrooms that grow in parts of South America, Mexico, and the United States. For 
more information, see the Hallucinogens and Dissociative Drugs Research Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 
Little Smoke, Magic 
Mushrooms, Purple 
Passion, Shrooms 
No commercial uses Fresh or dried 
mushrooms with long, 
slender stems topped by 
caps with dark gills 
Swallowed (eaten, 
brewed as tea, or added 
to other foods) 
I 
Possible Health Effects 
Short-term Hallucinations, altered perception of time, inability to tell fantasy from reality, panic, muscle 
relaxation or weakness, problems with movement, enlarged pupils, nausea, vomiting, 
drowsiness. 
Long-term Risk of flashbacks and memory problems. 
Other Health-related 
Issues 
Risk of poisoning if a poisonous mushroom is accidentally used. 
In Combination with 
Alcohol 





Medications It is not known whether psilocybin is addictive. There are no FDA-approved medications to 
treat addiction to psilocybin or other hallucinogens. 
Behavioral Therapies More research is needed to find out if psilocybin is addictive and whether behavioral 
therapies can be used to treat addiction to this or other hallucinogens. 
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Salvia 
A dissociative drug that is an herb in the mint family native to southern Mexico, Salvia divinorum. Dissociative drugs 
are hallucinogens that cause the user to feel detached from reality. For more information, see the Hallucinogens and 
Dissociative Drugs Research Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 




Sold legally in most 
states as Salvia 
divinorum. 
Fresh or dried leaves Smoked, chewed, or 











Possible Health Effects 
Short-term Short-lived but intense hallucinations; altered visual perception, mood, body sensations; 












Medications It is not known whether salvia is addictive. There are no FDA-approved medications to treat 
addiction to salvia or other dissociative drugs. 
Behavioral Therapies More research is needed to find out if salvia is addictive, but behavioral therapies can be 
used to treat addiction to dissociative drugs. 
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Steroids (Anabolic) 
Man-made substances used to treat conditions caused by low levels of steroid hormones in the body and abused to 
enhance athletic and sexual performance and physical appearance. For more information, see the Anabolic Steroid 
Abuse Research Report. 
Street Names Commercial Names 
(Common) 
Common Forms Common Ways Taken DEA 
Schedule 











Tablet, capsule, liquid 
drops, gel, cream, patch, 
injectable solution 
Injected, swallowed, 
applied to skin 
III 
Possible Health Effects 
Short-term Headache, acne, fluid retention (especially in the hands and feet), oily skin, yellowing of the 
skin and whites of the eyes, infection at the injection site. 
Long-term Kidney damage or failure; liver damage; high blood pressure, enlarged heart, or changes in 
cholesterol leading to increased risk of stroke or heart attack, even in young people; 
aggression; extreme mood swings; anger (“roid rage”); paranoid jealousy; extreme 
irritability; delusions; impaired judgment. 
Other Health-related 
Issues 
Males: shrunken testicles, lowered sperm count, infertility, baldness, development of 
breasts, increased risk for prostate cancer. 
 
Females: Facial hair, male-pattern baldness, menstrual cycle changes, enlargement of the 
clitoris, deepened voice. 
 
Adolescents: Stunted growth. 
Risk of HIV, hepatitis, and other infectious diseases from shared needles. 
In Combination with 
Alcohol 
Increased risk of violent behavior. 
Withdrawal 
Symptoms 
Mood swings; tiredness; restlessness; loss of appetite; insomnia; lowered sex drive; 
depression, sometimes leading to suicide attempts. 
Treatment Options 
Medications Hormone therapy 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat steroid 
addiction. 
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Synthetic Cannabinoids (“K2”/”Spice”) 
A wide variety of herbal mixtures containing man-made cannabinoid chemicals related to THC in marijuana but often 
much stronger and more dangerous. Sometimes misleadingly called “synthetic marijuana” and marketed as a 
“natural,” "safe," legal alternative to marijuana. For more information, see the Spice (“Synthetic Marijuana”) 
DrugFacts. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 
K2, Spice, Black 
Mamba, Bliss, Bombay 
Blue, Fake Weed, Fire, 
Genie, Moon Rocks, 
Skunk, Smacked, 
Yucatan, Zohai 
No commercial uses Dried, shredded plant 
material that looks like 
potpourri and is 
sometimes sold as 
“incense” 
Smoked, swallowed 
(brewed as tea) 
I 
Possible Health Effects 
Short-term Increased heart rate; vomiting; agitation; confusion; hallucinations, anxiety, paranoia; 




Use of synthetic cannabinoids has led to an increase in emergency room visits in certain 
areas. 





Headaches, anxiety, depression, irritability. 
Treatment Options 
Medications There are no FDA-approved medications to treat K2/spice addiction. 
Behavioral Therapies More research is needed to find out if behavioral therapies can be used to treat synthetic 
cannabinoid addiction. 
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Tobacco 
Plant grown for its leaves, which are dried and fermented before use. For more information, see the 
Tobacco/Nicotine Research Report. 
Street Names Commercial Names Common Forms Common Ways Taken DEA 
Schedule 
None Multiple brand names cigarettes, cigars, bidis, 
hookahs, smokeless 






Possible Health Effects 
Short-term Increased blood pressure, breathing, and heart rate. 
Long-term Greatly increased risk of cancer, especially lung cancer when smoked and oral cancers when 
chewed; chronic bronchitis; emphysema; heart disease; leukemia; cataracts; pneumonia. 
Other Health-related 
Issues 
Pregnancy: miscarriage, low birth weight, premature delivery, stillbirth, learning and 
behavior problems. 





Irritability, attention and sleep problems, increased appetite. 
Treatment Options 
Medications  Bupropion (Zyban®) 
 Varenicline (Chantix®) 
 Nicotine replacement (gum, patch, lozenge) 
Behavioral Therapies  Cognitive-behavioral therapy (CBT) 
 Self-help materials 
 Mail, phone, and Internet quit resources 
 
Federal Trafficking Penalties for Schedules I, II, III, IV, and V (except Marijuana) 
Schedule Substance/Quantity Penalty Substance/Quantity Penalty 
II Cocaine 
500-4999 grams mixture 
First Offense: Not less than 
5 yrs. and not more than 40 
yrs. If death or serious 
bodily injury, not less than 
20 yrs. or more than life. 
Fine of not more than $5 
million if an individual, $25 
million if not an individual. 
 
Second Offense: Not less 
than 10 yrs. and not more 
than life. If death or serious 
bodily injury, life 
imprisonment. Fine of not 
more than $8 million if an 
individual, $50 million if not 
an individual. 
Cocaine 
5 kilograms or more 
mixture 
First Offense: Not less than 
10 yrs. and not more than 
life. If death or serious 
bodily injury, not less than 
20 yrs. or more than life. 
Fine of not more than $10 
million if an individual, $50 
million if not an individual. 
 
Second Offense: Not less 
than 20 yrs, and not more 
than life. If death or serious 
bodily injury, life 
imprisonment. Fine of not 
more than $20 million if an 
individual, $75 million if not 
an individual. 
 
2 or More Prior Offenses: 
Life imprisonment. Fine of 
not more than $20 million if 
an individual, $75 million if 
not an individual. 
II Cocaine Base 
28-279 grams mixture 
Cocaine Base 
280 grams or more mixture 
IV Fentanyl 
40-399 grams mixture 
Fentanyl 
400 grams or more mixture 
I Fentanyl Analogue 
10-99 grams mixture 
Fentanyl Analogue 
100 grams or more mixture 
I Heroin 
100-999 grams mixture 
Heroin 
1 kilogram or more mixture 
I LSD 
1-9 grams mixture 
LSD 
10 grams or more mixture 
II Methamphetamine 
5-49 grams pure or 
50-499 grams mixture 
Methamphetamine 
50 grams or more pure 
or 500 grams or more 
mixture 
II PCP 
10-99 grams pure or 
100-999 grams mixture 
PCP 
100 grams or more pure 
or 1 kilogram or more 
mixture 
     
Substance/Quantity Penalty 
Any Amount Of Other Schedule I & II 
Substances 
First Offense: Not more that 20 yrs. If death or serious bodily injury, not less than 20 yrs. 
or more than Life. Fine $1 million if an individual, $5 million if not an individual. 
 
Second Offense: Not more than 30 yrs. If death or serious bodily injury, life 
imprisonment. Fine $2 million if an individual, $10 million if not an individual. 
Any Drug Product Containing Gamma 
Hydroxybutyric Acid 
Flunitrazepam (Schedule IV) 
1 Gram 
Any Amount Of Other Schedule III 
Drugs 
First Offense: Not more than 10 yrs. If death or serious bodily injury, not more that 15 
yrs. Fine not more than $500,000 if an individual, $2.5 million if not an individual. 
 
Second Offense: Not more than 20 yrs. If death or serious injury, not more than 30 yrs. 
Fine not more than $1 million if an individual, $5 million if not an individual. 
Any Amount Of All Other Schedule IV 
Drugs (other than one gram or more 
of Flunitrazepam) 
First Offense: Not more than 5 yrs. Fine not more than $250,000 if an individual, $1 
million if not an individual. 
 
Second Offense: Not more than 10 yrs. Fine not more than $500,000 if an individual, $2 
million if other than an individual. 
Any Amount Of All Schedule V Drugs First Offense: Not more than 1 yr. Fine not more than $100,000 if an individual, $250,000 
if not an individual. 
 
Second Offense: Not more than 4 yrs. Fine not more than $200,000 if an individual, 
$500,000 if not an individual. 
 
Federal Trafficking Penalties for Marijuana, Hashish and Hashish Oil, Schedule I Substances 
Marijuana 
1,000 kilograms or more marijuana 
mixture or 1,000 or more marijuana 
plants 
First Offense: Not less than 10 yrs. or more than life. If death or serious bodily injury, not 
less than 20 yrs., or more than life. Fine not more than $10 million if an individual, $50 
million if other than an individual. 
 
Second Offense: Not less than 20 yrs. or more than life. If death or serious bodily injury, 
life imprisonment. Fine not more than $20 million if an individual, $75 million if other than 
an individual. 
Marijuana 
100 to 999 kilograms marijuana 
mixture or 100 to 999 marijuana 
plants 
First Offense: Not less than 5 yrs. or more than 40 yrs. If death or serious bodily injury, not 
less than 20 yrs. or more than life. Fine not more than $5 million if an individual, $25 
million if other than an individual. 
 
Second Offense: Not less than 10 yrs. or more than life. If death or serious bodily injury, 
life imprisonment. Fine not more than $8 million if an individual, $50million if other than 
an individual. 
Marijuana 
50 to 99 kilograms marijuana mixture, 
50 to 99 marijuana plants 
First Offense: Not more than 20 yrs. If death or serious bodily injury, not less than 20 yrs. 
or more than life. Fine $1 million if an individual, $5 million if other than an individual. 
 
Second Offense: Not more than 30 yrs. If death or serious bodily injury, life imprisonment. 
Fine $2 million if an individual, $10 million if other than an individual. 
Hashish 
More than 10 kilograms 
Hashish Oil 
More than 1 kilogram 
Marijuana 
less than 50 kilograms marijuana (but 
does not include 50 or more marijuana 
plants regardless of weight) 
 
1 to 49 marijuana plants 
First Offense: Not more than 5 yrs. Fine not more than $250,000, $1 million if other than 
an individual. 
 
Second Offense: Not more than 10 yrs. Fine $500,000 if an individual, $2 million if other 
than individual. 
Hashish 
10 kilograms or less 
Hashish Oil 
1 kilogram or less 




Subject Applicable Law Applies to/unlawful 
to: 
Penalty/Sentence 
Alcohol 4301.62 Open container of 
alcohol in public 
Up to $100 fine 
Alcohol 4301.63 Purchase by minor Up to $1,000/ 
6 months 
Alcohol 4301.634 Misrepresentation by 
minor to obtain alcohol 
Up to $1,000 / 
6 months 
Alcohol 4301.636 Furnishing false 
identification cards 
Up to $1,000/ 
6 months 
Alcohol 4301.62 Consumption in motor 
vehicle 
Up to $250 
30 days 
Alcohol 4301.67 Possession of alcohol 
not lawfully acquired 
Up to $250 
30 days 





Marijuana 2925.03 Sale of: First offense $1,000 (mand.) 
1/2-5 years to 
$5,000 (mand.) 
2-15 years (depending 
on amount) 
Marijuana 2925.03 Sale of: Second offense 
or near school 
$2,000 (mand.) 
1-10 years to 
$10,000 (mand.) 
2-15 years (depending 
on amount) 










2925.11 Possession or use First 
Offense 










2925.03 Sale of: First offense $2,500 (mand.) 
1-10 years to 
$7,500 (mand.) 
15 years-life 




2925.03 Sale of: Second offense 
or near school 
$5,000 (mand.) 
2-15 years to 
$15,000 (mand.) 
20 years-life 
(depending on amount) 
All 2925.04 Illegal manufacture of 
drugs; illegal cultivation 
of marihuana 
 
Note: This summary is provided for informational purposes only and is not intended as legal advice. 
The information contained herein is not warranted to be current or complete. 




Subject Citation Applies to/unlawful to: Penalty/Sentence 
Alcohol NH RSA 179:5 Sell or give away any alcoholic beverage 
to a person under the age of 21 or to 
any intoxicated person regardless of 
age. 
Up to one year and/or 
$2,000 fine 
Alcohol NH RSA 178:1 Sale/exchange without a permit. Up to 7 years and/or 
$4,000 fine 
Alcohol NH RSA 179:9 Falsely represent age if under 21.. 
Violation is a misdemeanor for first 
offense, with a 
Minimum fine $500; 
second or subsequent 
offense, minimum 
$1,000. 
Alcohol NH RSA 179:10 Possess any liquor or alcoholic 
beverage, or be intoxicated by 
consumption of an alcoholic beverage 
(BAC .02% or more) if under 21. 
First offense, minimum 
$300; second offense, 
minimum $600. 
Alcohol NH RSA 
265A:44 
Operate a motor vehicle in which open 
containers of alcoholic beverages are 
found, if under 21. 
$150 fine and/or 
suspension for 60 days 
for a first offense; up to 
one year for 
subsequent offenses. 
Alcohol/Drugs NH RSA 265-A:2 Operate a motor vehicle while under 
the influence of alcohol or any 
controlled drug or any combination of 
alcohol and controlled drug. (BAC .08% 
21 or over; .02% under 21). 
Minimum $500; 
completion of 
program; revocation of 
90 days or more, and 
possible required drug 
or alcohol treatment. 
NH RSA 265-A:18. 





Illegal Drugs NH RSA 318- 
B:26 
Possess, manufacture, control, sell, 
purchase, administer, transport, 
dispense, possess with an intent to sell, 
package or repackage any controlled 
drug or controlled drug analog. 
Penalties for this 
offense vary according 
to the nature and the 
amount of the drug. 
See NH RSA 318-B:26 
for a list of all 
penalties. 
Illegal Drugs NH RSA 318-B:2 Deliver, possess with intent to deliver, 
or manufacture with intent to deliver, 
drug paraphernalia, knowing that it is 
intended to be used to plant, grow, 
harvest, manufacture, produce, process, 
Up to one year in jail, 
up to $2,000 fine. 
 
  prepare, test, analyze, pack, store, 
conceal, ingest, inhale, or otherwise 
introduce into the controlled substance 
into the human body. 
 
Note: This summary is provided for informational purposes only and is not intended as legal advice. The 
information contained herein is not warranted to be current or complete. 




Subject Citation Applies to/unlawful to: Penalty/Sentence 
Alcohol RCW 66.44 Persons under age 21 may not acquire, 
possess, or consume alcohol. Nor may 
other persons furnish alcohol to anyone 
under 21 or permit underaged 
consumption on premises within their 
control. Penalty: Maximum $500 fine, 2 
months’ imprisonment, or both. 
Maximum $500 fine, 
up to 2 months 
imprisonment, or both. 
Alcohol RCW 66.44 Persons under age 21 may not be in a 
public place or in a vehicle in public 
while exhibiting the effects of having 
consumed alcohol. A public place 
includes city streets and any buildings 
and grounds used for University 
purposes. 
Maximum $500 fine, 
up to 2 months 
imprisonment, or both. 
Alcohol RCW 66.44 Persons under 21 may not purchase or 
attempt to purchase alcohol. 
Maximum $1,000 fine, 
up to 90 days 
imprisonment, or both. 
Alcohol RCW 66.44 Alcohol may not be opened or 
consumed in a public place. 
Maximum $100 fine. 
 




Driving under the influence. 
(1) A person is guilty of driving while 
under the influence of intoxicating 
liquor, marijuana, or any drug if the 
person drives a vehicle within this state: 
(a) And the person has, within two 
hours after driving, an alcohol 
concentration of 0.08 or higher as 
shown by analysis of the person's 
breath or blood made under RCW 
46.61.506; or 
(b) The person has, within two hours 
after driving, a THC concentration of 
5.00 or higher as shown by analysis of 
the person's blood made under RCW 
46.61.506; or 
(c) While the person is under the 
influence of or affected by intoxicating 
liquor, marijuana, or any drug; or 
(d) While the person is under the 
combined influence of or affected by 
intoxicating liquor, marijuana, and any 
drug. 
Penalty may include 
fines, incarceration and 
suspension or loss of 
license. 
For BAC <.15%: 1-364 
days’ incarceration, 
fine  $350-$5,000; 
For BAC >.15%, 2-364 
days’ incarceration, 
fine of $500-$5,000. 
Prior offenses and 
refusal to submit to 
test result in additional 
penalties. 
 
Alcohol/Drugs    
Illegal Drugs RCW 69.50 It is unlawful to manufacture, deliver, 
or possess an illicit drug. 
Maximum $10,000 
fine, 5 years 
imprisonment, or both. 
Illegal Drugs RCW 69.50 It is unlawful to possess or use drug 
paraphernalia for purposes relating to 
the manufacture, delivery, possession, 
or use of an illicit drug. 
Penalty: Minimum 
$250 fine and not less 
than 24 hours in jail. 




It is unlawful to open a package 
containing marijuana, useable 
marijuana, or a marijuana-infused 
product, or consume marijuana, useable 
marijuana, or a marijuana-infused 
product, in view of the general public. 
A person who violates 
this section is guilty of 
a class 3 civil infraction 
under chapter 7.80 
RCW, with a default 
fine of $50. 
Note: This summary is provided for informational purposes only and is not intended as legal advice. The 
information contained herein is not warranted to be current or complete. 



















Penalties include fines, incarceration, rehabilitation 
program, or combination thereof. 
Illegal 
Drugs 
Cal. Health and 
Safety Code 
11550 
“use or be 
under the 
influence of a 
controlled 
substance” 
Penalties include fines, incarceration, rehabilitation 
program, or combination thereof. 
Illegal 
Drugs 
Cal. Health and 
Safety Code 






Penalties include fines, incarceration, rehabilitation 
program, or combination thereof. 
Controlled 
Substances 







Penalties include fines, incarceration, rehabilitation 
program, or combination thereof. 






or possess for 
sale 
marijuana” 
<28.5 g is a misdemeanor punishable by fine of up to 
$100; >28.5 grams punishable by fine of up to $500, six 
months in jail or both. 






Up to one year imprisonment and fine of up to $500. 
 
Alcohol Cal. Penal 
Code 647(f) 
“be under the 
influence of 
alcohol in a 
public place 
and unable to 
exercise care 
for one's own 
safety or that 
of others” 









of alcohol or 
other 
intoxicants or 
First offense: fines up to $2,600, imprisonment up to 
six months, driver’s license 
suspension up to ten months and interlock ignition 
device required in some counties. 
Second offense: fines up to $2,800, imprisonment up to 
one year, driver’s license 
suspension up to two years and interlock ignition 
 
  with a blood 
alcohol level 
of .08% or 
higher” 
device required. 
3. Third offense: fines up to $18,000, imprisonment up 
to one year driver’s license 
suspension up to three years and interlock ignition 
device required. 
4. Refusal to submit to a blood alcohol content test: 
driving privileges are suspended 
for one year, for two years if there is a prior offense 
within 10 years and for three years 












(.01% or more) 
One year suspension, or one year delay in issuance. 




use or possess 
bath salts 
Misdemeanor , subject to fine. 
Note: This summary is provided for informational purposes only and is not intended as legal advice. The 
information contained herein is not warranted to be current or complete. 
 
 
 
 
 
. 
